SOT-109

N/A

Report date: 2025/03/17 16:59:27

Base Information

Drug NameSOT-109

Drug Alias NameSOT109SOT-109

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > Exatecan payload

Mechanisms of ActionAnti-Cadherin-17DNA topoisomerase I inhibitors

TargetsCadherin-17DNA topoisomerase I

Therapy Area/IndicationsSolid tumoursColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechia

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSOTIO Biotech a s

China Registration ClassN/A

Develop Information

Active CompaniesSOTIO Biotech a s

Inactive CompaniesN/A

Active IndicationsSolid tumoursColorectal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A